GleamWall
中文EN

ANGO ANGIODYNAMICS INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1275187 · Fiscal year ends 05/31

Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.2%
TTM net income YoY-2.6%
TTM EPS YoY-1.3%
Revenue 3-yr CAGR-1.1%
Net income 3-yr CAGR—

Margins

Gross margin55.7%
Operating margin-11.2%
Net margin-10.1%
FCF margin0.4%
EBITDA margin-4.3%

Returns

ROE-19.2%
ROA-13.0%
ROIC (approx.)-21.4%
Asset turnover1.28x

Leverage & solvency

Liabilities / assets32.2%
Debt / equity0.00x
Current ratio2.40x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.11x
Accruals ratio-14.4%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-08-312026Q4*2026-05-312026Q32026-02-282026Q22025-11-302026Q12025-08-312025Q4*2025-05-312025Q32025-02-282025Q22024-11-30
Income statement
Revenue$80.92M$86.61M$78.42M$79.43M$75.71M$80.16M$72.00M$72.84M
Cost of revenue$32.88M$39.83M$36.94M$34.65M$33.85M$37.94M$33.15M$32.94M
Gross profit$48.04M$46.77M$41.48M$44.78M$41.86M$42.22M$38.86M$39.91M
R&D expense$7.98M$8.18M$7.08M$7.77M$6.42M$6.59M$6.91M$6.43M
SG&A expense$12.47M$10.27M$10.72M$10.15M$12.55M$10.24M$10.49M$10.39M
Operating income-$7.30M-$10.20M-$12.95M-$6.12M-$10.66M-$5.79M-$9.97M-$11.09M
Pretax income-$7.30M-$11.04M-$8.07M-$6.36M-$10.84M-$6.11M-$4.41M-$10.85M
Income tax-$199,000$370,000$12,000-$5,000$65,000-$60,000-$2,000-$110,000
Net income-$7.10M-$11.40M-$8.08M-$6.35M-$10.90M-$6.05M-$4.41M-$10.74M
EBITDA-$1.80M-$4.60M-$7.36M-$378,000-$4.71M$45,000-$3.65M-$4.23M
EPS (basic)-0.17—-0.19-0.15-0.26—-0.11-0.26
EPS (diluted)-0.17—-0.19-0.15-0.26—-0.11-0.26
Weighted avg. shares (diluted)42.02M—41.60M41.54M41.17M—40.85M40.92M
Balance sheet
Cash & equivalents$33.97M$53.86M$37.81M$41.64M$38.76M$55.89M$44.76M$54.09M
Receivables$44.91M$48.33M$45.55M$44.43M$42.64M$42.89M$43.47M$43.16M
Inventory$54.95M$52.44M$58.58M$65.57M$62.26M$62.01M$63.10M$65.92M
Current assets$143.00M$163.39M$155.55M$161.35M$156.66M$168.32M$172.27M$175.36M
PP&E, net$27.73M$27.10M$29.14M$30.53M$31.07M$32.30M$32.53M$32.98M
Intangibles$61.89M$67.21M$65.49M$66.73M$68.38M$69.12M$70.93M$73.11M
Total assets$241.93M$267.16M$260.68M$269.68M$265.64M$280.14M$285.42M$291.55M
Current liabilities$59.69M$74.72M$66.07M$71.96M$68.28M$76.20M$77.97M$88.59M
Total liabilities$77.97M$96.34M$87.32M$93.35M$86.79M$97.17M$99.55M$104.78M
Shareholders' equity$163.96M$170.82M$173.36M$176.33M$178.85M$182.97M$185.87M$186.77M
Shares outstanding42.42M41.70M41.68M41.57M41.45M40.99M40.97M40.84M
Cash flow statement
Operating cash flow-$15.33M$17.45M-$3.11M$4.66M-$15.91M$18.81M-$13.16M$2.47M
Capital expenditure$379,000$413,000$1.01M$422,000$731,000$777,000$1.80M$797,000
Free cash flow-$15.71M$17.04M-$4.12M$4.24M-$16.64M$18.03M-$14.96M$1.68M
Investing cash flow-$3.15M-$1.27M-$1.51M-$1.62M-$1.55M-$2.62M-$3.19M-$1.96M
Financing cash flow-$1.38M-$108,000$621,000-$92,000$143,000-$5.77M$7.15M-$1.12M
Depreciation & amortization$5.50M$5.60M$5.59M$5.75M$5.95M$5.83M$6.32M$6.86M
Stock-based compensation$4.50M$3.92M$2.70M$2.90M$4.47M$1.64M$2.40M$2.50M
Share buybacks—$0$0$0$0$0$0$1.12M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.